Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CMND · NASDAQ · Pharmaceutical Preparations · Foreign private issuer
Clearmind Medicine (CMND) · oqro.io/stocks/CMND · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$4.53−0.09 (−1.95%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Traded Jun 12 – Jun 16, 2026 · largest single transaction ~$73KNot reported under a pre-arranged trading plan
Jun 16, 2026~$73K · 22K sh @ $3.31
DetailsOfficial recordJun 15, 2026~$11K · 3,183 sh @ $3.32
DetailsOfficial recordJun 12, 2026~$7.1K · 2,102 sh @ $3.36
DetailsOfficial recordInsider buying
Traded Jun 10 · filed 2 days later
Since the trade −82.3% · S&P 500 +4.0% · to Nov 13
A major shareholder of Clearmind Medicine paid $330K out of pocket for Clearmind Medicine shares.
Insider selling
Traded Jun 11 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −83.0% · S&P 500 +2.3% · to Nov 13
A major shareholder of Clearmind Medicine sold $28K of Clearmind Medicine shares. The filing does not indicate a pre-arranged trading plan.
No earnings release (8-K Item 2.02) is on file for CMND, so its insider trades cannot be placed against one.
